Sublingual misoprostol in management of missed abortion in India.

Trop Doct

Department of Obstetrics and Gynaecology, Pt BD Sharma Post Graduate Institute of Medical Sciences, 21/9J Medical Enclave, Rohtak-124001, Haryana, India.

Published: January 2007

This prospective study was carried out at a tertiary care hospital on 50 women with missed abortion up to 13 weeks who were given 600 mug misoprostol sublingually every 3 h for a maximum of three doses. Success rate was 86% (up to 72 h), and the acceptability of the method was 69.7%. Sublingual misoprostol is a non-invasive, effective and safe medical method for completion of abortion in missed abortion.

Download full-text PDF

Source
http://dx.doi.org/10.1258/004947507779952023DOI Listing

Publication Analysis

Top Keywords

missed abortion
12
sublingual misoprostol
8
misoprostol management
4
management missed
4
abortion
4
abortion india
4
india prospective
4
prospective study
4
study carried
4
carried tertiary
4

Similar Publications

Early missed abortion is defined as a pregnancy of ≤ 12 weeks in which there is a cessation of life in the developing embryo or fetus, leading to its retention within the uterine cavity without being spontaneously expelled promptly. This condition is commonly observed and significantly impacts human reproductive health. This study aimed to identify key genes related to ferroptosis that could serve as novel biomarkers for early missed abortion.

View Article and Find Full Text PDF

Case report: A rare but fatal complication of hysteroscopy-air embolism during treatment for missed abortion.

Front Med (Lausanne)

December 2024

Department of Obstetrics and Gynecology, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China.

Hysteroscopic procedures complicated by air embolism (AE) are exceptionally rare occurrences in clinical practice, and there have been no previously reported cases of AE associated with hysteroscopic dilation and curettage. While the overall incidence of this complication is low, the consequences can be devastating. During early pregnancy, the unique physiological changes, such as elevated hormonal levels and increased uterine blood supply, significantly heighten the risk of AE development.

View Article and Find Full Text PDF

Society of Family Planning Clinical Recommendation: Medication management for early pregnancy loss.

Contraception

December 2024

Planned Parenthood South Atlantic, Raleigh, NC, USA and McLeod Regional Medical Center, Florence, SC, USA; University of Washington Department of Obstetrics and Gynecology, 1959 NE Pacific St, Box 356460, Seattle, WA 98005, USA; Pegasus Health Justice Center, Dallas, TX, 75207, USA; Washington University, St. Louis, MO, USA.

Early pregnancy loss (EPL), also known as miscarriage or spontaneous abortion, makes up 15-20% of all clinically recognized pregnancies. EPL is a broad term that includes intrauterine pregnancies (IUPs) with findings that suggest the pregnancy may not progress or definitely will not progress; pregnancies with a gestational sac (GS) in the lower endometrial cavity or endocervical canal in the process of expulsion; residual pregnancy tissue or persistent GS; and complete passage of the GS without residual tissue. This document addresses medication management of EPL in which the complete passage of the GS has not yet occurred, including pregnancies concerning for and diagnostic of EPL (sometimes called "missed abortion") and EPL in progress.

View Article and Find Full Text PDF

Ectopic pregnancies are uncommon among women presenting for abortion. However, where suspected, rapid referral for definitive diagnosis is essential to prevent harm. We assessed whether implementation of a standardised decision-making tool, an algorithmic representation of the clinical decisions and associated actions defined in policy, in a British abortion service was associated with a reduction in missed opportunities to escalate care where indicated.

View Article and Find Full Text PDF

Background: Missed abortion in the first trimester is characterized by the cessation of embryonic or fetal development while the cervix remains closed, often resulting in little to no bleeding. Ultrasound examinations typically reveal an empty gestational sac or an embryo/fetus that lacks cardiac activity. Misoprostol is the primary medication used to manage early pregnancy loss.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!